Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model

M Tournissac, TM Vu, N Vrabic, C Hozer… - Alzheimer's Research & …, 2021 - Springer
Background Old age, the most important risk factor for Alzheimer's disease (AD), is
associated with thermoregulatory deficits. Brown adipose tissue (BAT) is the main …

Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease

C Branca, EV Wisely, LK Hartman, A Caccamo… - Neurobiology of …, 2014 - Elsevier
Currently, there are no available approaches to cure or slow down the progression of
Alzheimer's disease (AD), which is characterized by the accumulation of extracellular …

[HTML][HTML] Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation

M Tournissac, P Bourassa, RD Martinez-Cano… - Molecular …, 2019 - Elsevier
Objective Old age is associated with a rise in the incidence of Alzheimer's disease (AD) but
also with thermoregulatory deficits. Indicative of a link between the two, hypothermia induces …

Metabolic determinants of Alzheimer's disease: A focus on thermoregulation

M Tournissac, M Leclerc, J Valentin-Escalera… - Ageing Research …, 2021 - Elsevier
Alzheimer's disease (AD) is a complex age-related neurodegenerative disease, associated
with central and peripheral metabolic anomalies, such as impaired glucose utilization and …

Memory loss caused by β-amyloid protein is rescued by a β3-adrenoceptor agonist

ME Gibbs, D Maksel, Z Gibbs, X Hou, RJ Summers… - Neurobiology of …, 2010 - Elsevier
Accumulation of the neurotoxic β-amyloid protein (Aβ) in the brain is a key step in the
pathogenesis of Alzheimer's disease (AD). Although transgenic mouse models of AD have …

Impaired thermoregulation and beneficial effects of thermoneutrality in the 3× Tg-AD model of Alzheimer's disease

M Vandal, PJ White, M Tournissac, C Tremblay… - Neurobiology of …, 2016 - Elsevier
The sharp rise in the incidence of Alzheimer's disease (AD) at an old age coincides with a
reduction in energy metabolism and core body temperature. We found that the triple …

Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial …

PM Ardestani, AK Evans, B Yi, T Nguyen, L Coutellier… - …, 2017 - Elsevier
Degeneration of noradrenergic neurons occurs at an early stage of Alzheimer's Disease
(AD). The noradrenergic system regulates arousal and learning and memory, and has been …

Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer's disease mice

G Chai, Y Wang, A Yasheng… - Neural regeneration …, 2016 - journals.lww.com
Impaired hippocampal neurogenesis is one of the early pathological features of Alzheimer's
disease. Enhancing adult hippocampal neurogenesis has been pursued as a potential …

Roles of β-adrenergic receptors in Alzheimer's disease: Implications for novel therapeutics

JT Yu, ND Wang, T Ma, H Jiang, J Guan, L Tan - Brain Research Bulletin, 2011 - Elsevier
Alzheimer's disease (AD), the most common cause of age-related dementia, is a progressive
neurodegenerative disorder with an enormous unmet medical need. In recent years, several …

β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?

GD Femminella, G Rengo, G Pagano… - Journal of …, 2013 - content.iospress.com
Alzheimer's disease (AD) is a devastating form of dementia that imposes a severe burden on
health systems and society. Although several aspects of AD pathogenesis have been …